ツムラの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/11/18 | 2,960 | 2,968 | 2,947 | 2,957 | +9 | +0.3% | 117,800 |
| 2022/11/17 | 2,903 | 2,959 | 2,902 | 2,948 | +31 | +1.1% | 104,800 |
| 2022/11/16 | 2,910 | 2,922 | 2,890 | 2,917 | +3 | +0.1% | 90,500 |
| 2022/11/15 | 2,934 | 2,950 | 2,913 | 2,914 | -19 | -0.6% | 111,400 |
| 2022/11/14 | 2,965 | 2,970 | 2,921 | 2,933 | -33 | -1.1% | 116,200 |
| 2022/11/11 | 2,980 | 2,985 | 2,956 | 2,966 | +4 | +0.1% | 182,400 |
| 2022/11/10 | 2,882 | 2,966 | 2,876 | 2,962 | +67 | +2.3% | 226,500 |
| 2022/11/09 | 2,882 | 2,908 | 2,880 | 2,895 | +25 | +0.9% | 190,400 |
| 2022/11/08 | 2,940 | 2,941 | 2,867 | 2,870 | -54 | -1.8% | 462,800 |
| 2022/11/07 | 2,920 | 2,950 | 2,835 | 2,924 | -116 | -3.8% | 385,600 |
| 2022/11/04 | 3,065 | 3,080 | 3,015 | 3,040 | -65 | -2.1% | 251,600 |
| 2022/11/02 | 3,080 | 3,130 | 3,055 | 3,105 | +55 | +1.8% | 129,700 |
| 2022/11/01 | 3,115 | 3,120 | 3,045 | 3,050 | -55 | -1.8% | 94,600 |
| 2022/10/31 | 3,080 | 3,115 | 3,080 | 3,105 | +35 | +1.1% | 136,400 |
| 2022/10/28 | 3,065 | 3,105 | 3,060 | 3,070 | -25 | -0.8% | 287,800 |
| 2022/10/27 | 3,130 | 3,135 | 3,080 | 3,095 | -55 | -1.7% | 86,300 |
| 2022/10/26 | 3,095 | 3,160 | 3,085 | 3,150 | +80 | +2.6% | 93,100 |
| 2022/10/25 | 3,080 | 3,090 | 3,060 | 3,070 | +10 | +0.3% | 71,700 |
| 2022/10/24 | 3,095 | 3,095 | 3,050 | 3,060 | -20 | -0.6% | 89,700 |
| 2022/10/21 | 3,080 | 3,095 | 3,045 | 3,080 | ±0 | ±0% | 124,700 |
| 2022/10/20 | 3,080 | 3,090 | 3,060 | 3,080 | -20 | -0.6% | 95,600 |
| 2022/10/19 | 3,090 | 3,125 | 3,090 | 3,100 | ±0 | ±0% | 65,400 |
| 2022/10/18 | 3,130 | 3,130 | 3,080 | 3,100 | +20 | +0.6% | 78,100 |
| 2022/10/17 | 3,100 | 3,135 | 3,080 | 3,080 | -60 | -1.9% | 74,400 |
| 2022/10/14 | 3,115 | 3,150 | 3,080 | 3,140 | +60 | +1.9% | 102,300 |
| 2022/10/13 | 3,085 | 3,085 | 3,060 | 3,080 | -35 | -1.1% | 87,000 |
| 2022/10/12 | 3,095 | 3,120 | 3,080 | 3,115 | +20 | +0.6% | 101,800 |
| 2022/10/11 | 3,090 | 3,125 | 3,075 | 3,095 | -40 | -1.3% | 108,900 |
| 2022/10/07 | 3,090 | 3,160 | 3,085 | 3,135 | +10 | +0.3% | 111,200 |
| 2022/10/06 | 3,125 | 3,155 | 3,115 | 3,125 | -35 | -1.1% | 197,800 |
| 2022/10/05 | 3,185 | 3,190 | 3,150 | 3,160 | -5 | -0.2% | 93,500 |
| 2022/10/04 | 3,125 | 3,175 | 3,120 | 3,165 | +105 | +3.4% | 152,800 |
| 2022/10/03 | 3,050 | 3,075 | 3,030 | 3,060 | -25 | -0.8% | 100,600 |
| 2022/09/30 | 3,100 | 3,125 | 3,070 | 3,085 | -15 | -0.5% | 137,700 |
| 2022/09/29 | 3,050 | 3,120 | 3,015 | 3,100 | +60 | +2% | 181,700 |
| 2022/09/28 | 2,975 | 3,040 | 2,975 | 3,040 | +30 | +1% | 131,900 |
| 2022/09/27 | 3,025 | 3,045 | 3,000 | 3,010 | +5 | +0.2% | 107,700 |
| 2022/09/26 | 2,985 | 3,010 | 2,976 | 3,005 | -20 | -0.7% | 201,100 |
| 2022/09/22 | 3,050 | 3,050 | 3,020 | 3,025 | -65 | -2.1% | 162,400 |
| 2022/09/21 | 3,065 | 3,110 | 3,060 | 3,090 | -25 | -0.8% | 161,100 |
| 2022/09/20 | 3,065 | 3,125 | 3,060 | 3,115 | +75 | +2.5% | 183,800 |
| 2022/09/16 | 3,030 | 3,060 | 3,030 | 3,040 | +30 | +1% | 180,800 |
| 2022/09/15 | 3,010 | 3,040 | 3,005 | 3,010 | -55 | -1.8% | 145,200 |
| 2022/09/14 | 3,090 | 3,100 | 3,055 | 3,065 | -80 | -2.5% | 134,600 |
| 2022/09/13 | 3,140 | 3,155 | 3,120 | 3,145 | +15 | +0.5% | 69,800 |
| 2022/09/12 | 3,160 | 3,170 | 3,110 | 3,130 | -20 | -0.6% | 135,700 |
| 2022/09/09 | 3,135 | 3,165 | 3,135 | 3,150 | -5 | -0.2% | 204,200 |
| 2022/09/08 | 3,160 | 3,175 | 3,130 | 3,155 | +35 | +1.1% | 166,000 |
| 2022/09/07 | 3,155 | 3,155 | 3,080 | 3,120 | -60 | -1.9% | 179,400 |
| 2022/09/06 | 3,185 | 3,220 | 3,155 | 3,180 | -15 | -0.5% | 87,000 |
601～
650
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| 住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ペプチド | 201,800円 | +5.0% | +1.5% | 0.00% | 17.33倍 | 4.61倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム
